SAR 31.95
(2.4%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 312.21 Million SAR | 44.66% |
2022 | 215.83 Million SAR | -26.72% |
2021 | 294.53 Million SAR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 341.34 Million SAR | 9.33% |
2023 FY | 312.21 Million SAR | 44.66% |
2023 Q4 | 312.21 Million SAR | 13.35% |
2023 Q2 | 275.43 Million SAR | 27.62% |
2022 Q4 | 215.83 Million SAR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 138.49 Million SAR | -125.426% |
Al-Dawaa Medical Services Company | 3.39 Billion SAR | 90.802% |
Nahdi Medical Company | 2.9 Billion SAR | 89.266% |
Al-Razi Medical Co. | 23.04 Million SAR | -1254.603% |